SYT13 and amyotrophic lateral sclerosis: In this study, the authors also found that the MNs still surviving within the spinal cord of end-stage ALS patients (most likely S type) had higher SYT13 mRNA levels compared to those found in non-affected controls, suggesting that this protein might help in protecting MNs during disease progression.